Ledger.Open graph →
SEC Form D · filed February 12, 2018

INNOVATE BIOPHARMACEUTICALS, INC

Offering
$92.8M
Sold
$92.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Raleigh, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Roy Proujansky · Raleigh, NCDirectorLorin Johnson · Raleigh, NCDirectorAnthony Maida · Raleigh, NCDirectorJay Madan · Raleigh, NCExec · DirectorChristopher Prior · Raleigh, NCExec · DirectorSandeep Laumas · Raleigh, NCExec · DirectorChristine Tsai · San Francisco, CADirectorVictor Gajendran · Los Angeles, CAExec · DirectorJeong Min Lim · San Francisco, CADirectorHui Chen · New York, NYExec · DirectorTodd R. Tarbert · BELLEVUE, WADirectorSanjay Anand · Los Angeles, CAExec · DirectorAnna Kazanchyan · Raleigh, NCDirectorDr. Melissa K. Rhodes · San Francisco, CADirectorKerry Faix · West Chester, PADirectorSteven Lloyd · West Chester, PAExec · DirectorJonas Pilkauskas · SAN FRANCISCO, CADirectorRomas Matiukas · SAN FRANCISCO, CAExec · DirectorKeith S. Greenfield · Boston, MAExec · DirectorAnna Kazanchyan · Raleigh, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗